Sun Pharmaceutical Industries (SUNPHARMA.BO) Earnings Analysis
Sun Pharmaceutical Industries (SUNPHARMA.BO) next reports earnings on 2026-07-31, consensus EPS 12.53 INR. Last quarter (2026-05-22) it missed with EPS 11.3 INR vs 11.34 INR est (-0.4%). It has beaten estimates in 4/7 recent quarters (57%). Trailing P/E 40.80.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does SUNPHARMA.BO next report earnings?
| Next earnings date | 2026-07-31 |
|---|---|
| Consensus EPS estimate | 12.53 INR |
| Revenue estimate | 154.74B |
SUNPHARMA.BO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-22 | 11.3 INR | 11.34 INR | -0.4% | Miss |
| 2026-01-31 | 14.7 INR | 12.91 INR | +13.9% | Beat |
| 2025-07-31 | 12 INR | 12.52 INR | -4.2% | Miss |
| 2025-05-22 | 10.8 INR | 11.65 INR | -7.3% | Miss |
| 2025-01-31 | 13.4 INR | 11.98 INR | +11.9% | Beat |
| 2024-10-28 | 12.7 INR | 11.62 INR | +9.3% | Beat |
| 2024-08-01 | 11.8 INR | 10.51 INR | +12.3% | Beat |
Beat rate: 4/7 (57%) over reported quarters with consensus data.
SUNPHARMA.BO valuation and analyst view
| Trailing P/E | 40.80 |
|---|---|
| Trailing EPS | 47.795 INR |
| Price / book | 5.61 |
| Dividend yield | 0.82% |
| Market cap | 4661.19B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Sun Pharmaceutical Industries (SUNPHARMA.BO)'s next earnings date?
Sun Pharmaceutical Industries is next scheduled to report on 2026-07-31, with a consensus EPS estimate of 12.53 INR and revenue estimate of 154.74B.
Did SUNPHARMA.BO beat earnings last quarter?
In its 2026-05-22 report, SUNPHARMA.BO posted EPS of 11.3 INR versus a 11.34 INR estimate — a miss of 0.4%.
What is SUNPHARMA.BO's earnings track record?
Over the last 7 reported quarters with consensus data, SUNPHARMA.BO beat estimates 4 times (57%).
What is SUNPHARMA.BO's current P/E ratio and EPS?
SUNPHARMA.BO trades at a trailing P/E of 40.80 on trailing EPS of 47.795149962777856 INR.
What do analysts rate SUNPHARMA.BO?
SUNPHARMA.BO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.